None listed
Conditions
Interventions
None listed
Sponsors
Catholic Kwandong University International St.Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adults aged 18 years or older who have been diagnosed with liver disease (chronic hepatitis, compensated or decompensated cirrhosis, or hepatocellular carcinoma) at International St. Mary’s Hospital and are undergoing treatment or follow-up evaluation Individuals for whom sufficient clinical information—such as laboratory tests, imaging studies, and histological examinations—is available to assess the diagnosis and severity of liver disease Individuals who voluntarily provide written informed consent to participate in the study (for prospective participants only)
Exclusion criteria
Exclusion criteria: Individuals who have taken antibiotics, immunosuppressants, or corticosteroids within the past 3 months and may have potential alterations in immune or metabolic function Women who are pregnant or breastfeeding Individuals deemed medically or ethically unsuitable for participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| hepatic fibrosis | — |
Countries
Korea, Republic of
Contacts
Public ContactSangheun Lee
Catholic Kwandong University International St.Mary's Hospital
Outcome results
None listed